Drugs / Lopinavir/ritonavir
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00605098 Comparator | Feb 2008 → Jul 2012 | HIV infectious disease | Oswaldo Cruz Foundation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lopinavir/ritonavir | “Drug: Lopinavir/ritonavir” NCT00605098 ↗ |
| Known as | LPV/r | “A lopinavir-ritonavir (LPV/r)-based regimen is recommended during pregnancy to reduce the risk of HIV mother-to-child transmission” PMID 24614377 ↗ Mar 2014 |